期刊
MATRIX BIOLOGY
卷 22, 期 1, 页码 63-71出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/S0945-053X(03)00005-2
关键词
thrombospondin; endothelial cell; proliferation; apoptosis
资金
- NHLBI NIH HHS [HL64387] Funding Source: Medline
- NIAMS NIH HHS [AR45418] Funding Source: Medline
Thrombospondins (TSPs) I and 2 are matricellular proteins with the well-characterized ability to inhibit angiogenesis in vivo, and the migration and proliferation of cultured microvascular endothelial cells (ECs). Angiogenesis in developing tumors and in various models of wound healing is diminished or delayed by the presence of TSPI or 2. Sequences within the type I repeats of TSPI and 2 have been demonstrated to mediate the anti-migratory effects of TSPs on microvascular EC, although, paradoxically, sequences in the N- and C-terminal domains have pro-angiogenic effects. A scavenger receptor, CD36, recognizes the active sequences in the type I repeats, and is required for the anti-angiogenic effects of TSPI in the corneal neovascularization assay. However, interactions of TSPs with growth factors, proteases, histidine-rich glycoprotein, and other cell-surface receptors on EC have the potential to modulate CD36-mediated effects. Binding of TSPI to CD36 has been shown to activate apoptosis by inducing p38 and Jun N-terminal kinase, members of the mitogen- activated protein kinase superfamily, and subsequently the cell-surface expression of FasL. Ligation of Fas by FasL then induces a caspase cascade and apoptotic cell death. However, we have recently shown that inhibition of proliferation of microvascular EC by TSPs can occur in the absence of cell death. This finding raises the possibility that TSPs can activate separate cell death and anti-proliferative pathways. (C) 2003 Elsevier Science B.V./International Society of Matrix Biology. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据